RECURSION PHARMACEUTICALS, INC. (RXRX) Revenue 2019–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$74.7MFY2025 · since FY2019: $2.3M → $74.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $74.7M | +26.9% |
| FY2024 | $58.8M | +32.0% |
| FY2023 | $44.6M | +11.9% |
| FY2022 | $39.8M | +291.5% |
| FY2021 | $10.2M | +156.9% |
| FY2020 | $4.0M | +70.8% |
| FY2019 | $2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice